1. Home
  2. Analysis
  3. Sulfadiazine
  4. Trizivir

Sulfadiazine and Trizivir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 14 people who take Sulfadiazine and Trizivir. Common interactions include alanine aminotransferase increased among females, and encephalitis among males.

The phase IV clinical study analyzes what interactions people who take Sulfadiazine and Trizivir have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

14 people who take Sulfadiazine and Trizivir together, and have interactions are studied.

What is Sulfadiazine?

Sulfadiazine has active ingredients of sulfadiazine. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 2,083 Sulfadiazine users.

What is Trizivir?

Trizivir has active ingredients of abacavir sulfate; lamivudine; zidovudine. It is used in hiv infection. Currently, eHealthMe is studying from 2,747 Trizivir users.

Number of Sulfadiazine and Trizivir reports submitted per year:

Sulfadiazine and Trizivir drug interactions.

Common Sulfadiazine and Trizivir drug interactions by gender *:

female:

  1. Alanine aminotransferase increased
  2. Anaemia
  3. Aspartate aminotransferase increased
  4. Bone marrow depression
  5. Gamma-glutamyltransferase increased
  6. Megakaryocytes
  7. Oesophageal candidiasis
  8. Pancytopenia
  9. Red cell aplasia
  10. Bone marrow disorder

male:

  1. Encephalitis
  2. Rash erythematous
  3. Multi-organ failure
  4. Pyrexia
  5. Sepsis
  6. Stomatitis
  7. Tachycardia
  8. Acute circulatory failure
  9. Agitation
  10. Cardiac disorder

Common Sulfadiazine and Trizivir drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Encephalitis
  2. Rash erythematous
  3. Hyponatraemia
  4. Rash
  5. Alanine aminotransferase increased
  6. Anaemia
  7. Aspartate aminotransferase increased
  8. Bone marrow depression
  9. Gamma-glutamyltransferase increased
  10. Megakaryocytes

50-59:

  1. Epidermal necrolysis
  2. Hypotension
  3. Tachycardia
  4. Acute circulatory failure
  5. Agitation
  6. Cardiac disorder
  7. Dermatitis
  8. Disorientation
  9. Eye disorder
  10. Eyelid oedema

60+:

n/a

Common conditions people have *:

  1. Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 2 people, 14.29%
  2. Fungal Infection: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfadiazine and Trizivir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Sulfadiazine drug interactions:

Browse interactions between Sulfadiazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Trizivir drug interactions:

Browse interactions between Trizivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfadiazine and abacavir sulfate; lamivudine; zidovudine (the active ingredients of Sulfadiazine and Trizivir, respectively), and Sulfadiazine and Trizivir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sulfadiazine and Trizivir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.